A Ahuja, N Oh, W Chao, RG Spragg and RM Smith
Department of Medicine, University of California, San Diego, USA.

Production of oxygen radicals by phagocytic cells and loss of surfactant function have each been implicated in the pathogenesis of acute lung injury. Therapeutic administration of exogenous surfactant to injured lungs in which neutrophils are the dominant cell type has been proposed. To understand the role of surfactant in modulating pulmonary inflammation and the impact of surfactant supplementation on diseased lungs, we studied the effect of native porcine and synthetic surfactant preparations on human neutrophil respiratory burst oxidase activity in vitro. We found that surfactant inhibited neutrophil superoxide production induced by either receptor-mediated [formylmethionylleucylphenylalanine (fMLP)] or non-receptor-mediated [phorbol myristate acetate (PMA)] agonists with an IC50 of approximately 0.015 mg phospholipid/ml for porcine surfactant or approximately 0.050 mg phospholipid/ml for synthetic surfactant. Surfactant had no effect on detection of superoxide generation in a noncellular system using xanthine and xanthine oxidase and only minimally inhibited superoxide generation by neutrophils that had been fully stimulated by prior exposure to PMA. There was no effect of surfactant on neutrophil calcium mobilization in response to fMLP, on lactoferrin release in response to PMA, or on membrane protein kinase C activity in response to PMA. Suspensions of dipalmitylphosphatidylcholine alone had no effect on neutrophil superoxide production. Taken together, these findings indicate that certain components of lung surfactant may effect relatively late steps in the activation of the respiratory burst or may alter subsequent steps involved in the assembly of the respiratory burst oxidase.

This article has been cited by other articles:

				M. R. White, E. Crouch, J. Vesona, P. J. Tacken, J. J. Batenburg, R. Leth-Larsen, U. Holmskov, and K. L. Hartshorn Respiratory innate immune proteins differentially modulate the neutrophil respiratory burst response to influenza A virus Am J Physiol Lung Cell Mol Physiol, October 1, 2005; 289(4): L606 - L616. [Abstract] [Full Text] [PDF]

				A. Tonks, J. Parton, A. J. Tonks, R. H. K. Morris, A. Finall, K. P. Jones, and S. K. Jackson Surfactant phospholipid DPPC downregulates monocyte respiratory burst via modulation of PKC Am J Physiol Lung Cell Mol Physiol, June 1, 2005; 288(6): L1070 - L1080. [Abstract] [Full Text] [PDF]

				W. Bernhard, P. L. Haslam, and J. Floros From Birds to Humans: New Concepts on Airways Relative to Alveolar Surfactant Am. J. Respir. Cell Mol. Biol., January 1, 2004; 30(1): 6 - 11. [Abstract] [Full Text] [PDF]

				M. E. Boston, G. C. Frech, E. Chacon-Cruz, E. S. Buescher, and D. G. Oelberg Surfactant Releases Internal Calcium Stores in Neutrophils by G Protein-Activated Pathway Experimental Biology and Medicine, January 1, 2004; 229(1): 99 - 107. [Abstract] [Full Text] [PDF]

				R. G. Spragg, J. F. Lewis, W. Wurst, D. Hafner, R. P. Baughman, M. D. Wewers, and J. J. Marsh Treatment of Acute Respiratory Distress Syndrome with Recombinant Surfactant Protein C Surfactant Am. J. Respir. Crit. Care Med., June 1, 2003; 167(11): 1562 - 1566. [Abstract] [Full Text] [PDF]

				J. L. Malloy, R. A. W. Veldhuizen, F. X. McCormack, T. R. Korfhagen, J. A. Whitsett, and J. F. Lewis Pulmonary surfactant and inflammation in septic adult mice: role of surfactant protein A J Appl Physiol, February 1, 2002; 92(2): 809 - 816. [Abstract] [Full Text] [PDF]

				W. Bernhard, S. Hoffmann, H. Dombrowsky, G. A. Rau, A. Kamlage, M. Kappler, J. J. Haitsma, J. Freihorst, H. von der Hardt, and C. F. Poets Phosphatidylcholine Molecular Species in Lung Surfactant . Composition in Relation to Respiratory Rate and Lung Development Am. J. Respir. Cell Mol. Biol., December 1, 2001; 25(6): 725 - 731. [Abstract] [Full Text] [PDF]

				A. M. LeVine, J. A. Whitsett, J. A. Gwozdz, T. R. Richardson, J. H. Fisher, M. S. Burhans, and T. R. Korfhagen Distinct Effects of Surfactant Protein A or D Deficiency During Bacterial Infection on the Lung J. Immunol., October 1, 2000; 165(7): 3934 - 3940. [Abstract] [Full Text] [PDF]

				F. Pinot, H. Walti, H. P. Haagsman, B. S. Polla, and M. Bachelet Curosurf modulates cAMP accumulation in human monocytes through a membrane-controlled mechanism Am J Physiol Lung Cell Mol Physiol, January 1, 2000; 278(1): L99 - L104. [Abstract] [Full Text] [PDF]

				A. SUWABE, K. OTAKE, N. YAKUWA, H. SUZUKI, M. ITO, H. TOMOIKE, Y. SAITO, and K. TAKAHASHI Artificial Surfactant (Surfactant TA) Modulates Adherence and Superoxide Production of Neutrophils Am. J. Respir. Crit. Care Med., December 1, 1998; 158(6): 1890 - 1899. [Abstract] [Full Text] [PDF]

				A. M. LeVine, K. E. Kurak, M. D. Bruno, J. M. Stark, J. A. Whitsett, and T. R. Korfhagen Surfactant Protein-A-Deficient Mice Are Susceptible to Pseudomonas aeruginosa Infection Am. J. Respir. Cell Mol. Biol., October 1, 1998; 19(4): 700 - 708. [Abstract] [Full Text]